• Sibannac holds a 51% controlling stake in Apollo Wellness Centers, a joint venture with Doc-Rx under an October 1, 2026, agreement.
• Apollo expects branded wellness clinics to become its largest revenue source, using a licensing model rather than owning locations.
• Clinics would be owned by licensed prescribers ordering through Doc-Rx, whose existing platform provides telehealth, partner compounding pharmacies and health tracking.
• The venture also plans its own peptide, nutraceutical and medical food products, alongside expanded telemedicine services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sibannac Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610270630ACCESSWRNAPR_____1242281) on October 27, 2026, and is solely responsible for the information contained therein.